Fundraising Fox
Endeavor Biomedicines
San Diego, US · Founded 2018 · Delaware corporation · 52 employees on LinkedIn · 3 known investors
Find your way into Endeavor Biomedicines
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jon Edwards to introduce you to John Hood
You →Jon · together at Impact Biomedicines, Inc. →John
Sign up to find every way you can get introduced to Endeavor Biomedicines
- Your email: who you already know at Endeavor Biomedicines, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Endeavor Biomedicines team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.
Founders & leadership
Endeavor Biomedicines was founded in 2018 by John Hood.
Board
Investors · 3
How we know: the company's own site · Not right? Tell us
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$221.7M disclosed across 2 rounds · 2022–2024
▶$132.6MraisedMay 2024 · 32 investors · BiotechnologyRule 506(b)
- Patrick G. EnrightDirector
- Bernard DavitianDirector
- John HoodExecutive Officer, Director
- Vishaal TurakhiaExecutive Officer
- Chris KruegerExecutive Officer
- Enoch KariukiExecutive Officer
- Karan TakharDirector
- Miguel de los RiosExecutive Officer
- Monal MehtaDirector
- Wing Cheong LamDirector
- Offering amount
- $132.6M
- Amount sold
- $132.6M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$89.1MraisedFeb 2022 · 16 investors · BiotechnologyRule 506(b)
- Wing Cheong LamDirector
- Bernard DavitianDirector
- Raghu SaripalliExecutive Officer
- John HoodDirector, Executive Officer
- Monal MehtaDirector
- Patrick G. EnrightDirector
- Miguel de los RiosExecutive Officer
- Offering amount
- $101M
- Amount sold
- $89.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Endeavor Biomedicines went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Endeavor Biomedicines.
Frequently asked questions
- What does Endeavor Biomedicines do?
- Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.
- Who founded Endeavor Biomedicines?
- Endeavor Biomedicines was founded by John Hood in 2018.
- Who are Endeavor Biomedicines's investors?
- Endeavor Biomedicines's investors include Fidelity Investments, Longitude Capital, Omega Funds.
- How much funding has Endeavor Biomedicines raised?
- Endeavor Biomedicines has disclosed $221.7M raised across 2 rounds.
- Where is Endeavor Biomedicines headquartered?
- Endeavor Biomedicines is headquartered in San Diego, US.